Clifford Cho

907 total citations
14 papers, 219 citations indexed

About

Clifford Cho is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Clifford Cho has authored 14 papers receiving a total of 219 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Clifford Cho's work include Pancreatic and Hepatic Oncology Research (8 papers), Neuroendocrine Tumor Research Advances (8 papers) and Lung Cancer Research Studies (8 papers). Clifford Cho is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Neuroendocrine Tumor Research Advances (8 papers) and Lung Cancer Research Studies (8 papers). Clifford Cho collaborates with scholars based in United States, Italy and Canada. Clifford Cho's co-authors include Shishir K. Maithel, Sharon M. Weber, David A. Kooby, Carl Schmidt, Emily R. Winslow, Hari Nathan, Ryan C. Fields, Sarah B. Fisher, Mark Bloomston and Paula Marincola Smith and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American College of Surgeons.

In The Last Decade

Clifford Cho

14 papers receiving 217 citations

Peers

Clifford Cho

ONCOL

SURGE

PRM

EPIDE

NEURO

Masahiro Shiihara Japan

Roberto Grassia Italy

Yoshihide Nanno Japan

Vasileios Smyrniotis Greece

Kenji Shimura Japan

Giovanna Sabella Italy

Anna Caterina Milanetto Italy

Ds Klimstra United States

Amir Mearadji Netherlands

Ioannis Karoumpalis Greece

Masahiro Shiihara Japan

Clifford Cho

192 ×1.1

ONCOL

139 ×1.4

SURGE

65 ×0.8

PRM

65 ×0.9

EPIDE

21 ×0.6

NEURO

Citations per year, relative to Clifford Cho Clifford Cho (= 1×) peers Masahiro Shiihara

Countries citing papers authored by Clifford Cho

Since Specialization

Citations

This map shows the geographic impact of Clifford Cho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clifford Cho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clifford Cho more than expected).

Fields of papers citing papers by Clifford Cho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clifford Cho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clifford Cho. The network helps show where Clifford Cho may publish in the future.

Co-authorship network of co-authors of Clifford Cho

This figure shows the co-authorship network connecting the top 25 collaborators of Clifford Cho. A scholar is included among the top collaborators of Clifford Cho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clifford Cho. Clifford Cho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Makris, Eleftherios, Jeffrey A. Norton, Alexandra G. Lopez‐Aguiar, et al.. (2022). Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine Tumors. Annals of Surgical Oncology. 30(4). 2424–2430. 3 indexed citations

Carpenter, Eileen S., Sarah C. Nelson, Filip Bednar, et al.. (2021). Immunotherapy for pancreatic ductal adenocarcinoma. Journal of Surgical Oncology. 123(3). 751–759. 21 indexed citations

Baechle, Jordan J., Paula Marincola Smith, Carmen C. Solórzano, et al.. (2020). Specific Growth Rate as a Predictor of Survival in Pancreatic Neuroendocrine Tumors: A Multi-institutional Study from the United States Neuroendocrine Study Group. Annals of Surgical Oncology. 27(10). 3915–3923. 3 indexed citations

Dong, Dinghui, Xu‐Feng Zhang, Alexandra G. Lopez‐Aguiar, et al.. (2020). Surgical outcomes of patients with duodenal vs pancreatic neuroendocrine tumors following pancreatoduodenectomy. Journal of Surgical Oncology. 122(3). 442–449. 2 indexed citations

Ganguly, Anutosh, Ryan Hubbard, Tejaswi Worlikar, et al.. (2020). 730 Histotripsy focused ultrasound ablation induces immunological cell death in treated and distant untreated tumors. SHILAP Revista de lepidopterología. A437.1–A437. 5 indexed citations

Heidsma, Charlotte M., Madison Hyer, Diamantis I. Tsilimigras, et al.. (2020). Incidence and impact of Textbook Outcome among patients undergoing resection of pancreatic neuroendocrine tumors: Results of the US Neuroendocrine Tumor Study Group. Journal of Surgical Oncology. 121(8). 1201–1208. 27 indexed citations

Barrett, James R., Victoria R. Rendell, Courtney Pokrzywa, et al.. (2020). Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit. Journal of Surgical Oncology. 121(7). 1067–1073. 19 indexed citations

Kamarajah, Sivesh K., Christopher J. Sonnenday, Clifford Cho, et al.. (2019). Association of adjuvant radiotherapy with survival after margin-negative resection of pancreatic ductal adenocarcinoma: a propensity-matched national cancer database (ncdb) analysis. HPB. 21. S310–S310. 18 indexed citations

Smith, Paula Marincola, Jordan J. Baechle, Carmen C. Solórzano, et al.. (2019). Impact of perioperative blood transfusion on survival in pancreatic neuroendocrine tumor patients: analysis from the US Neuroendocrine Study Group. HPB. 22(7). 1042–1050. 5 indexed citations

10.

Chakedis, Jeffery, Eliza W. Beal, Alexandra G. Lopez‐Aguiar, et al.. (2018). Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms. Journal of Gastrointestinal Surgery. 23(1). 122–134. 21 indexed citations

11.

Tran, Nguyen H., Vaibhav Sahai, Kent A. Griffith, et al.. (2018). Neoadjuvant FOLFIRINOX and IMRT concurrent with FDR-gemcitabine in patients with borderline resectable pancreatic cancer (BRPC).. Journal of Clinical Oncology. 36(4_suppl). 381–381. 4 indexed citations

12.

Lopez‐Aguiar, Alexandra G., Mohammad Y. Zaidi, Mary Dillhoff, et al.. (2018). Defining the role of lymphadenectomy for pancreatic neuroendocrine tumors: An eight institution study of 695 patients from the U.S. Neuroendocrine Tumor Study Group.. Journal of Clinical Oncology. 36(4_suppl). 212–212. 5 indexed citations

13.

Wilson, Gregory C., Shishir K. Maithel, David J. Bentrem, et al.. (2017). Are the Current Guidelines for the Surgical Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas Adequate? A Multi-Institutional Study. Journal of the American College of Surgeons. 224(4). 461–469. 28 indexed citations

14.

Fisher, Sarah B., Sameer H. Patel, David A. Kooby, et al.. (2012). Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis. HPB. 14(8). 514–522. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact